Impact of Osmotically Active Excipients on Bioavailability and Bioequivalence of BCS Class III Drugs

Схожие документы

• The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers
  по: Parr, Alan, et al.
  Опубликовано: (2015)
• Scientific Perspectives on Extending the Provision for Waivers of In vivo Bioavailability and Bioequivalence Studies for Drug Products Containing High Solubility-Low Permeability Drugs (BCS-Class 3)
  по: Stavchansky, Salomon
  Опубликовано: (2008)
• Bioavailability and Bioequivalence in Drug Development
  по: Chow, Shein-Chung
  Опубликовано: (2014)
• Per-6-Thiolated Cyclodextrins: A Novel Type of Permeation Enhancing Excipients for BCS Class IV Drugs
  по: Asim, Mulazim Hussain, et al.
  Опубликовано: (2020)
• In Vitro Considerations to Support Bioequivalence of Locally Acting Drugs in Dry Powder Inhalers for Lung Diseases
  по: Lee, Sau Lawrence, et al.
  Опубликовано: (2009)